In Algeria, as of 2011 about 70,000 people were infected with hepatitis C. As of August 2015, Gilead had licensed its partners in India to sell sofosbuvir in Algeria.
Di Aljazair, pada tahun 2011 sekitar 70.000 orang terinfeksi hepatitis C. Pada Agustus 2015, Gilead memberikan lisensi kepada mitra-mitranya di India untuk menjual sofosbuvir di Aljazair.